Literature DB >> 25063958

Commingling analysis of age-of-onset in bipolar I disorder and the morbid risk for major psychoses in first degree relatives of bipolar I probands.

Maria Grigoroiu-Serbanescu1, Marcella Rietschel2, Joanna Hauser3, Piotr M Czerski3, Stefan Herms4, Xianqing Sun5, Priya Wickramaratne6, Robert C Elston5.   

Abstract

BACKGROUND: Age-of-onset (AO) is increasingly used in molecular genetics of bipolar I disorder (BP-I) as a phenotypic specifier with the goal of reducing genetic heterogeneity. However, questions regarding the cut-off age for defining early onset (EO), as well as the number of onset groups characterizing BP-I have emerged over the last decade with no definite conclusion. The aims of this paper are: 1) to see whether a mixture of three distributions better describes the AO of BP-I than a mixture of two distributions in different independent samples; 2) to compare the morbid risk (MR) for BP-I and for major affective disorders and schizophrenia in first degree relatives of BP-I probands by proband onset group derived from commingling analysis, since the MR to relatives is a trait with strong genetic background.
METHODS: We applied commingling (admixture) analysis to the AO of three BP-I samples from Romania (n=621), Germany (n=882), and Poland (n=354). Subsequently, the morbid risk (MR) for BP-I and for major psychoses (BP-I, BP-II, Mdd-UP, schizoaffective disorders, schizophrenia) was estimated in first degree relatives by proband AO-group derived from admixture analysis in the Romanian sample.
RESULTS: In the three independent samples and in the combined sample two- and three-AO-group distributions fitted the empirical data equally well. The upper EO limit varied between 21 and 25 years from sample to sample. The MR for both BP-I and for all major psychoses was similar in first degree relatives of EO probands (AO≤21) and in relatives of intermediate-onset probands (AO=22-34). Significant MR differences appeared only when comparing the EO group to the late-onset (LO) group (AO>34). Similar to Mdd-UP and schizophrenia, a significant MR decrease in proband first degree relatives was visible after proband AO of 34 years. Under the three-AO-group classification the MR for both BP-I and all major psychoses in first degree relatives did not differ by relative sex in any proband AO-group. Under the two-AO-group classification female relatives of LO probands (AO>24) had a significantly higher MR for all major psychoses than male relatives, while there was no sex difference for the relatives of EO probands. LIMITATIONS: MR was not computed in the German and Polish samples because family data were not available and 34% of the relatives of the Romanian probands were not available for direct interview.
CONCLUSION: Similar to other clinical traits, the MR for major psychoses to relatives failed to support a three-AO-group classification in BP-I suggesting that this is not more useful for the molecular analysis than a two-AO-group classification.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Admixture analysis; Affective disorders; Molecular analysis; Morbid risk; Onset; Sex differences

Mesh:

Year:  2014        PMID: 25063958     DOI: 10.1016/j.jad.2014.06.054

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

Review 1.  The genetics of early-onset bipolar disorder: A systematic review.

Authors:  Kevin P Kennedy; Kathryn R Cullen; Colin G DeYoung; Bonnie Klimes-Dougan
Journal:  J Affect Disord       Date:  2015-05-15       Impact factor: 4.839

2.  The cAMP responsive element-binding (CREB)-1 gene increases risk of major psychiatric disorders.

Authors:  X Xiao; C Zhang; M Grigoroiu-Serbanescu; L Wang; L Li; D Zhou; T-F Yuan; C Wang; H Chang; Y Wu; Y Li; D-D Wu; Y-G Yao; M Li
Journal:  Mol Psychiatry       Date:  2017-11-21       Impact factor: 15.992

3.  The genome-wide risk alleles for psychiatric disorders at 3p21.1 show convergent effects on mRNA expression, cognitive function, and mushroom dendritic spine.

Authors:  Zhihui Yang; Danyang Zhou; Huijuan Li; Xin Cai; Weipeng Liu; Lu Wang; Hong Chang; Ming Li; Xiao Xiao
Journal:  Mol Psychiatry       Date:  2019-11-13       Impact factor: 15.992

4.  Clinical correlates of age at onset distribution in bipolar disorder: a comparison between diagnostic subgroups.

Authors:  Mirko Manchia; Giuseppe Maina; Bernardo Carpiniello; Federica Pinna; Luca Steardo; Virginia D'Ambrosio; Virginio Salvi; Martin Alda; Alfonso Tortorella; Umberto Albert
Journal:  Int J Bipolar Disord       Date:  2017-08-21

5.  Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study.

Authors:  Janos L Kalman; Sergi Papiol; Andreas J Forstner; Urs Heilbronner; Franziska Degenhardt; Jana Strohmaier; Mazda Adli; Kristina Adorjan; Nirmala Akula; Martin Alda; Heike Anderson-Schmidt; Till Fm Andlauer; Ion-George Anghelescu; Raffaella Ardau; Bárbara Arias; Volker Arolt; Jean-Michel Aubry; Lena Backlund; Kim Bartholdi; Michael Bauer; Bernhard T Baune; Thomas Becker; Frank Bellivier; Antonio Benabarre; Susanne Bengesser; Abesh Kumar Bhattacharjee; Joanna M Biernacka; Armin Birner; Clara Brichant-Petitjean; Monika Budde; Pablo Cervantes; Caterina Chillotti; Sven Cichon; Scott R Clark; Francesc Colom; Ashley L Comes; Cristiana Cruceanu; Piotr M Czerski; Udo Dannlowski; Alexandre Dayer; Maria Del Zompo; Jay Raymond DePaulo; Detlef E Dietrich; Bruno Étain; Thomas Ethofer; Peter Falkai; Andreas Fallgatter; Christian Figge; Laura Flatau; Here Folkerts; Louise Frisen; Mark A Frye; Janice M Fullerton; Katrin Gade; Sébastien Gard; Julie S Garnham; Fernando S Goes; Maria Grigoroiu-Serbanescu; Anna Gryaznova; Maria Hake; Joanna Hauser; Stefan Herms; Per Hoffmann; Liping Hou; Markus Jäger; Stephane Jamain; Esther Jiménez; Georg Juckel; Jean-Pierre Kahn; Layla Kassem; John Kelsoe; Sarah Kittel-Schneider; Sebastian Kliwicki; Farah Klohn-Sagatholislam; Manfred Koller; Barbara König; Carsten Konrad; Nina Lackner; Gonzalo Laje; Mikael Landén; Fabian U Lang; Catharina Lavebratt; Marion Leboyer; Susan G Leckband; Mario Maj; Mirko Manchia; Lina Martinsson; Michael J McCarthy; Susan L McElroy; Francis J McMahon; Philip B Mitchell; Marina Mitjans; Francis M Mondimore; Palmiero Monteleone; Vanessa Nieratschker; Caroline M Nievergelt; Tomas Novák; Urban Ösby; Andrea Pfennig; James B Potash; Daniela Reich-Erkelenz; Andreas Reif; Jens Reimer; Eva Reininghaus; Markus Reitt; Stephan Ripke; Guy A Rouleau; Janusz K Rybakowski; Martin Schalling; Harald Scherk; Max Schmauß; Peter R Schofield; K Oliver Schubert; Eva C Schulte; Sybille Schulz; Fanny Senner; Giovanni Severino; Tatyana Shekhtman; Paul D Shilling; Christian Simhandl; Claire M Slaney; Carsten Spitzer; Alessio Squassina; Thomas Stamm; Sophia Stegmaier; Sebastian Stierl; Pavla Stopkova; Andreas Thiel; Sarah K Tighe; Alfonso Tortorella; Gustavo Turecki; Eduard Vieta; Julia Veeh; Martin von Hagen; Moritz E Wigand; Jens Wiltfang; Stephanie Witt; Adam Wright; Peter P Zandi; Jörg Zimmermann; Markus Nöthen; Marcella Rietschel; Thomas G Schulze
Journal:  Bipolar Disord       Date:  2018-06-28       Impact factor: 6.744

6.  Novel splice‑site variants c.393G>A, c.278_2A>G in exon 2 and Q705K variant in exon 3 of NLRP3 gene are associated with bipolar I disorder.

Authors:  Kuyaş Heki̇mler Öztürk; Güli̇n Özdamar Ünal
Journal:  Mol Med Rep       Date:  2022-08-03       Impact factor: 3.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.